Skip to main content

ABOUT DERMOZONE

Dermozone Indonesia was established in 2008 in Indonesia. The company CEO and founder, Kayapan Satya Dharshan, has spent years for research and design where he invented and holds Intellectual Property for the machine and active compound named +dalethyne, which is a breakthrough invention, drug of choice to serve broad spectrum wounds and nosocomial infections.

 

The novel compound is a breakthrough that revolutionize the world of wound healing and skin care, and has been tested by world accredited laboratory and have the ability to eliminate nosocomial infection, which prominently known to cause sudden deaths and become healthcare institutions’ biggest challenge worldwide for its resistance to antibiotics.

At present active compound +dalethyne is exclusively used in Dermozone’s products: MedCare® (wound healing) and Body Care (skin treatment).

 

Headquartered in Jakarta, Indonesia, our global offices are operating in Japan, India and Korea.


This is a demo store for testing purposes — no orders shall be fulfilled.

Shopping Cart